Sensulin Appoints Advisory Board

Advisory Board for biotech company is chaired by past ADA President, includes past CEOs of the JDRF and Amylin, former Franchise Head for Merck’s diabetes and obesity division, etc. Chicago, July 11, 2013---- Sensulin, LLC, a leader in the development of novel medicines for diabetes, announced its Advisory Board during the American Diabetes Association’s (ADA) 73rd Scientific Sessions.